Notably, the combination of sh-CMTM6-Exos and RS504383 resulted in the most significant tumor suppression (Figure 6M), suggesting a potential additive or synergistic interaction between exosomal CMTM6 and CCL2 signaling in promoting CC progression. This evidence concerns the gene CCL2 and neoplasm.